Skip to main content
. 2024 Sep 4;6(12):101208. doi: 10.1016/j.jhepr.2024.101208

Table 1.

Characteristics of patients with PSVD or cirrhosis and HVs.

PSVD (n = 20) Cirrhosis (n = 20) HVs (n = 20) p value
Age, years 51.0 (36.3-55.0) 53.0 (44.0-60.1) 52.2 (39.7-58.9) 0.414
Male sex 13 (65.0%) 16 (80.0%) 13 (65.0%) 0.699
BMI, kg/m2 25.6 (22.9-28.4) 25.9 (25.0-27.7) - 0.791
History of decompensation 6 (30.0%) 8 (40.0%) - 0.740
LSM, kPa 7.8 (5.9-8.8) 30.2 (23.9-67.5) - <0.001
HVPG, mmHg 5 (4-8) 18 (13-19) - <0.001
Child-Pugh score, points 6 (5-7) 6 (5-6) - 0.522
 Child-Pugh stage A 14 (70.0%) 16 (80.0%) - 0.715
 Child-Pugh stage B/C 6 (30.0%) 4 (20.0%) -
MELD 8 (7-10) 8 (8-10) - 0.699
Platelet count, G/L 82 (63-117) 84 (70-113) - 0.642
Albumin, g/dl 42.7 (39.8-44.5) 39.5 (36.8-40.7) - 0.009
Spleen length, cm 16.0 (14.5-17.5) 14.0 (12.0-15.0) 0.040
Specific clinical signs of portal hypertension 20 (100%) 20 (100%) - -
 Varices 19 (95.0%) 19 (95.0%) - 1.000
 Portosystemic collaterals 18 (90.0%) 15 (75.0%) - 0.405
Unspecific clinical signs of portal hypertension 19 (95.0%) 19 (95.0%) - 1.000
 Ascites 2 (10.0%) 8 (40.0%) - 0.068
 Thrombocytopenia 16 (80.0%) 18 (90.0%) - 0.661
 Splenomegaly 18 (90.0%) 14 (70.0%) - 0.235

HV, healthy volunteers; HVPG, hepatic venous pressure gradient; LSM, liver stiffness measurement; PSVD, porto-sinusoidal vascular disorder; Student’s t test, Mann-Whitney U test, Pearson's Chi-squared test, Fisher’s exact test. Bold value represents p <0.05.